Methods for treating dermatomyositis or polymyositis by administering a soluble CTLA4 molecule
US10052360B2 · kind B2 · utility
0Cited by
59References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 19, 2016 |
| Grant date | Aug 21, 2018 |
| Priority date | — |
| Expiry date | Oct 3, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods for treating autoimmune diseases by administering to a subject a CTLA4 molecule that block endogenous B7 molecules from binding their ligands.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.